The MAPK/ERK signal pathway is well-established as one of the most important pathways in NSCLC, stimulating our interest in whether HBXIP could promote NSCLC development through the MAPK/ERK pathway. The gene discussed is LAMTOR5; the disease is non-small cell lung carcinoma.